economic instability, natural disasters, rising raw material prices and, yes, a strong Swiss franc. This has made for an extremely tough, volatile and competitive environment. But by leveraging our competitive advantages, investing behind our growth drivers and excelling in operational efficiency and effectiveness, we managed to drive growth
Words: 8008 - Pages: 33
Strategic Management Biocon – Term Paper Name: Naresh.N Section: B Semester : 3rd Batch : 2011-2013 PES Institute of Technology 2012 1/1/2012 INTRODUCTION Industry Biotechnology Founded 1978 Founder(s) Kiran Mazumdar-Shaw Headquarters Bangalore, India Biocon Limited (BSE: 532523) is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization
Words: 4681 - Pages: 19
Teva Strategy Overview February 21, 2008 Forward-Looking Statements TODAY S PRESENTATION CONTAINS FORWARD-LOOKING STATEMENTS, WHICH EXPRESS THE CURRENT BELIEFS AND EXPECTATIONS OF MANAGEMENT. SUCH STATEMENTS INVOLVE A NUMBER OF KNOWN AND UNKNOWN RISKS AND UNCERTAINTIES THAT COULD CAUSE TEVA'S FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS TO DIFFER SIGNIFICANTLY FROM THE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY SUCH FORWARDLOOKING STATEMENTS. IMPORTANT FACTORS THAT COULD
Words: 7679 - Pages: 31
The enterprise app store Evolution in IT strategy WWW.WIPRO.COM Author: Prasenjit Bhadra, Principal Architect – Wipro Mobility Solutions From consumers to the work place: An App-t evolution Apple created a revolution with its app store. Consumers loved it. Naturally, other players are rushing in to meet consumer expectations. Vendors like Amazon, Google and Microsoft have begun to offer similar stores that have a self-service model. With the widespread adoption of mobility within
Words: 2177 - Pages: 9
exit the industry for prescription pharmaceuticals, while aiming to help students to recognise how to set boundaries for an industry. This is a detailed industry note on the “ethical” pharmaceutical industry which provides an opportunity to analyse key success factors of major players. The note centres on a descriptive overview of the predominant issues in the three major Triad market areas: the US, Europe and Japan (although major issues in emerging markets are also mentioned). The note covers the
Words: 8602 - Pages: 35
Performance of Indian firms before and after entry of foreign firms Under the Guidance of Prof. Saptarshi Purkayastha Under the Guidance of Prof. Saptarshi Purkayastha Submitted by: Group 6, Section B JAYASHREE LANJEKAR PGP/16/024 HEMANT KUMAR PGP/16/083 NISHANTH S PGP/16/096 T DURGALAKSHMI PGP/16/115 ARKAPRABHA DEBNATH PGP/16/133 UMESH KUMAR (GL) PGP/16/174 Submitted by: Group 6, Section B JAYASHREE LANJEKAR PGP/16/024 HEMANT KUMAR PGP/16/083 NISHANTH S PGP/16/096 T
Words: 5970 - Pages: 24
FMCG NOVEMBER 2011 Contents Advantage India Market overview and trends Growth drivers Success stories: Major players Opportunities Useful information For updated information, please visit www.ibef.org 2 FMCG NOVEMBER 2011 Advantage India Growing demand • Attractive opportunities • 2018E Market size: USD74 billion Rising disposable income of the young population has been a major growth driver for the sector Emergence of organised retail has boosted the distribution of FMCG sector
Words: 3711 - Pages: 15
Background Automotive industry is the key driver of any growing economy. Due to its deep forward and backward connections with almost every segment of the economy(for example Indian automobile industry is the largest customer of Steel industry in India), the industry has a strong and positive multiplier effect and thus propels progress of a nation. The automotive industry comprises of the automobile and the auto component sectors. It includes passenger cars; light, medium and heavy commercial
Words: 2477 - Pages: 10
High-Technology Acquisitions Final Project -Acquisition Proposal: To Acquire: May 2012 Table of Content Executive Summary I A. Purpose I B. Background I C. The Rational for the Acquisition I D. Standalone, Synergy and Premium Valuations II E. Integration Plan II Part 1 - The Rational of the Acquisition 1 1. Pfizer's Strategy 1 1.1. Pfizer Growth Strategy 2 2. Pfizer's Road Map 4 2.1. Pfizer's Acquisitions Rational 4 3. The strategy behind the acquisition
Words: 10031 - Pages: 41
Industry Insight Nutraceuticals February 2008 4th & 5th Floghts, Road No. 1, Banjara Hills, Hyderabad-500034, India Tel: +91-40-23430303-05, Fax: +91-40-23430201, E-mail: info@cygnusindia.com Website: www.cygnusindia.com Disclaimer: All information contained in this report has been obtained from sources believed to be accurate by Cygnus Business Consulting & Research (Cygnus). While reasonable care has been taken in its preparation, Cygnus makes no representation or warranty, express or
Words: 36372 - Pages: 146
